Introduction
============

Modern high-yielding dairy cows enter a state of negative energy balance (NEB) around calving when the energy demand for maintenance and lactation exceeds that of dietary energy intake ([@bib5]). Cows with excessive body tissue mobilisation at this stage may take up to 20 weeks to regain a positive energy balance status ([@bib63]). Although the resumption of ovarian activity is initiated during NEB (Beam & Butler 1999), there are subsequent effects on fertility that lead to poor conception rates ([@bib70], [@bib71]). Previous studies have examined possible effects of NEB on the oocyte (e.g. [@bib33]), ovary (e.g. [@bib34]) and uterus (e.g. [@bib8]) but work on the oviduct is limited, although it provides a crucial environment for gamete transport, sperm capacitation, fertilisation and early embryonic development ([@bib13], [@bib27]). In a normal cyclic animal, the secretory activity of the oviduct increases during the periovulatory period and early luteal phase ([@bib42], [@bib7]), so that proteins are expressed on the epithelial apical surface or released into the oviductal lumen, which can enhance both sperm survival ([@bib6]) and embryo development ([@bib32]). Such secretory activity is decreased during the luteal phase and pregnancy, thought to be due to the prevailing high concentration of progesterone ([@bib43]), but resumes following parturition ([@bib59], [@bib10]).

Previous work has shown that amongst the metabolites and metabolic hormones that change in relation to NEB, insulin-like growth factor-I (IGF-I) is strongly associated with the calving to conception interval and pregnancy outcome ([@bib70], [@bib64]). The nutritional sensitivity of IGF-I is widely reported ([@bib66]) and we and others have shown that severe NEB (SNEB) during early lactation attenuates gene transcription of IGF-I and also a number of IGF-related members in the liver, producing an endocrine environment of reduced IGF-I stability and bioavailability ([@bib37], [@bib16]). IGFs have a broad range of functions to promote differentiation, stimulate mitogenesis and inhibit apoptosis ([@bib29]). The IGF system comprises a second ligand (IGF-II), two receptors (IGF-1R and IGF-2R) and at least six binding proteins (IGFBP). This complexity serves to enable differential regulation of the IGF system within different tissues ([@bib11]).

Transcripts for IGF-I and IGF-II have been detected in the oviduct of ruminants ([@bib58], [@bib61]), primates ([@bib19]) and rodents ([@bib9]). Specific localisation studies have further shown that IGF-I expression mainly predominates in the mucosa and IGF-II in the muscularis ([@bib53], [@bib54]). Purified isolates of oviductal epithelial cells produce and secrete both IGF-I and IGF-II ([@bib74]) as well as the regulatory binding proteins IGFBP-2 and IGFBP-3 ([@bib22]). IGF-I and IGF-II in a variety of species are generally regulated in a positive manner with ovarian oestradiol production ([@bib74], [@bib9], [@bib61], [@bib19]). The presence of an IGF system in the oviduct suggests that the IGFs may act as important modulators of oviductal function.

For many tissue types, support and maintenance rely on the presence of an adequate IGF system which may be derived from both an endocrine source like the liver or produced locally in a paracrine/autocrine manner. Circulating IGF-I concentrations fall in the immediate postpartum period in dairy cows and may not return to pre-partum levels for more than 12 weeks in some cows (Taylor *et al*. 2004*a*). Restoration of oviductal activity therefore occurs in an endocrine environment of low IGF-I. Waves of follicular activity resume after about 10--14 days ([@bib57]) but progesterone concentrations remain low until after the first ovulation. In dairy cows from the same herd as that used for the present study, the interval to commencement of luteal activity was 31±15 days (mean±[[s.d.]{.smallcaps}]{.smallcaps}) and was shorter in cows having higher IGF-I concentrations in the first 2 weeks after calving ([@bib48]). The uterus is also undergoing involution during this period, a process which is normally complete in 30--50 days ([@bib21]). Microbial contamination of the bovine uterus is almost universal during the first week postpartum, and the rate of bacterial clearance also affects the return to normal cyclicity ([@bib60]).

At present, virtually nothing is known about the potential regulatory effects of NEB on oviduct function and we postulated that the global effects of NEB might influence local gene expression during the recovery period. The specific aims of this study were thus to determine the effects of NEB on oviductal IGF transcript expression during the early postpartum interval.

Results
=======

Metabolic and hormonal effects of NEB
-------------------------------------

Results are reported for the day of tissue collection, which was on days 6--7 of the first follicular wave after calving, that is, before any cow had ovulated. This occurred on days 14±0.7 postpartum (*n*=6, ranges 11--16) in the mild NEB (MNEB) group and days 14±0.7 postpartum (*n*=6, ranges 12--16) in the SNEB group. Exposing cows to a regime of differential milking frequency and dietary intake during the first 2 weeks postpartum produced two groups with altered metabolic indices at the time of tissue collection ([Table 1](#tbl1){ref-type="table"}), although average daily milk yield at the time of sample collection did not differ between groups (21.7±0.83 kg, *n*=12). This is because the SNEB cows were simultaneously stimulated to produce extra milk by 3× milking, and limited in their potential for additional milk production by the dietary energy restriction. This resulted in a SNEB and large degree of body tissue mobilisation, as evidenced from the blood metabolite data. Concentrations of circulating IGF-I (*P*=0.001) and glucose (*P*=0.001) were lower in SNEB relative to MNEB cows, while non-esterified fatty acids (NEFA; *P*=0.007) and β-hydroxybutyrates (BHB; *P*=0.001) concentrations were elevated. Urea concentrations tended to be higher in the SNEB cows (*P*=0.075). These differences were reflected in the actual energy balance calculations, which tended to be lower in the SNEB group (*P*=0.079).

Plasma concentrations of GH, insulin, oestradiol and cortisol did not differ significantly between the two groups (*P*\>0.1). At the time of tissue collection, the sizes of the dominant follicles were also similar: 15.0±0.69 and 12.2±1.25 mm respectively in the MNEB and SNEB groups. The diameter of the previously gravid uterine horn was larger than that of the previously non-gravid uterine horn (59±6.4 and 33±2.2 mm respectively, mean±[[s.e.m.]{.smallcaps}]{.smallcaps}, *P*=0.005), but these measurements did not differ between groups. This large difference between horns indicates that, as expected, uterine involution was not yet complete at this stage.

Effect of NEB on the expression of IGF family members and related hormone receptors in the oviduct
--------------------------------------------------------------------------------------------------

The real-time RT-PCR data, based on whole oviducts, revealed that expression of IGFBP-2 and IGFBP-6 was significantly lower in the SNEB cows ([Table 2](#tbl2){ref-type="table"}). There were no other differences according to EB status for other members of the IGF family or in the other receptors examined (insulin receptor type A/B, IR-A/B, oestrogen receptor α/β, ERα/β, glucocorticoid receptor α, GRα and growth hormone receptor, GHR). The concentration of 18SrRNA measured was similar between groups. IGF-2R was only detected in 3 out of 12 oviducts, and IGFBP-1 was undetectable in 10 out of 12 samples (data not shown). These findings were closely confirmed by analysis of the *in situ* hybridisation data from the opposite oviduct ([Table 3](#tbl3){ref-type="table"}). Using this technique, there was a highly significant (*P*=0.009) reduction in IGFBP-6 expression in the SNEB cows, and a strong tendency towards reduced IGFBP-2 expression in the same cows (*P*=0.068). Overall, levels of the IGFBP-6 transcript were reduced in SNEB cows by more than twofold relative to MNEB cows as detected by both real-time PCR and *in situ* hybridisation. No other members of the IGF family examined showed significant differences according to EB status.

Localisation of IGFs in the oviduct
-----------------------------------

Localisation patterns within the oviduct are illustrated in [Figs 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and a summary of the expression of measured traits according to region is presented in [Table 3](#tbl3){ref-type="table"}. Isthmus was not present in oviduct sections from three cows in each group. IGF-I mRNA was localised to the luminal epithelium of the oviduct by *in situ* hybridisation, and expression levels did not vary between the ampulla, isthmus and infundibulum. IGF-II expression was found in the muscle and mucosa of all three oviductal regions and transcript levels were relatively higher in the isthmus compared with the ampulla and infundibulum (*P*=0.001). IGF-1R was detectable in the mucosa of all oviduct regions and no regional differences were evident. IGF-2R could not be reliably detected by this method (data not shown).

Expression of IGFBP-1 was likewise not detectable in the bovine oviduct by *in situ* hybridisation. IGFBP-2 hybridisation was evenly dispersed across the smooth muscle and mucosal layers in all regions. Strong antisense hybridisation was also noted in the outer adventitia ([Fig. 2](#fig2){ref-type="fig"}a). Expression of IGFBP-3 and IGFBP-4 mRNA was also evenly detectable in muscle and mucosal layers. Spatially, IGFBP-3 expression was higher in the isthmus than the infundibulum (*P*=0.035), with a similar trend for IGFBP-4 (*P*=0.056). IGFBP-5 mRNA was localised with relatively higher expression in the muscle layer and the isthmus region compared with the remainder of the oviduct (*P*=0.004; [Fig. 2](#fig2){ref-type="fig"}g). A region×treatment interaction for IGFBP-6 mRNA indicated reduced levels of expression in the ampulla of SNEB cows relative to that of MNEB cows (optical density OD units SNEB 0.136±0.055 and MNEB 0.327±0.054; *P*=0.006). There was strong intensity labelling in the mucosal aspect of the oviduct wall ([Fig. 2](#fig2){ref-type="fig"}i) with relatively higher levels in the ampulla and infundibular regions (*P*=0.001).

Gene expression relationships in the postpartum oviduct
-------------------------------------------------------

When values obtained from quantitative RT-PCR were considered regardless of treatment, a number of traits were identified that exhibited positive relationships in the postpartum oviduct ([Fig. 3](#fig3){ref-type="fig"}; all *P*=0.01). In particular, expression levels of IGF-I and GHR were strongly associated with each other (*r*=0.921) and levels of both of these gene transcripts were individually associated with IGF-1R and ERβ (see [Fig. 3](#fig3){ref-type="fig"}). Expression of the IGF-I transcript was also associated with IGF-II and GRα transcript levels and GHR was associated with IGFBP-6 transcript levels. ERβ levels were positively associated with GRα (*r*=0.912) and IGF-1R (*r*=0.761), while IR-B levels were positively associated with IR-A (*r*=0.835) and IGFBP-5 (*r*=0.772) (all *P*=0.01, not shown). No relationships were detected between gene expression and circulating oestradiol concentrations in individual cows.

Discussion
==========

Previous studies have indicated that members of the IGF family are expressed in the oviduct and are regulated by stage of the oestrous cycle ([@bib9], [@bib19], [@bib54]) yet little is known about the effect of energy balance on the regulation of IGFs in this important tissue. In our model of NEB, results show that neither the local production of IGF-I or IGF-II, nor any of the receptors associated with these ligands were affected by the different NEB regimes. By contrast, a comparative reduction in IGFBP-2 and IGFBP-6 mRNA was evident in oviducts from SNEB relative to MNEB cows. The net effect of these changes suggests that NEB may influence oviductal recovery and function postpartum by disrupting the balance of local IGF availability, rather than by having a direct affect on local IGF synthesis. Dairy cows are normally inseminated again from about 50--60 days after calving, whereas the time of sample collection at 2 weeks postpartum in this study was much earlier. This is a physiologically relevant time to investigate as it is close to the nadir in energy balance that occurs after calving and it also enabled samples to be collected without the likely confounding effect of differences in the stage of the oestrous cycle. Furthermore, high-yielding animals can take up to 20 weeks to regain a positive energy balance status after calving ([@bib63]). Their continued low circulating IGF-I concentrations over this period (Taylor *et al*. 2004*a*) suggests that the changes to the oviductal IGF system reported here may still be present during the service period in some cows.

The liver is the major source of IGF-I and IGF-II in the circulation ([@bib77]). In our model, the production of hepatic IGF-I was severely restricted in SNEB cows in association with a reduction in GHR but hepatic IGF-II mRNA was not significantly changed, so the ratio of IGF-II:IGF-I mRNA within the liver was increased. These data are consistent with those of others which showed a decline in GHR and IGF-I in the periparturient period ([@bib56]). Circulating IGF-II was not measured in the present experiment, but concentrations of IGF-II were about fourfold higher than those of IGF-I during pregnancy in heifers, and showed a lesser response to alterations in dietary protein ([@bib51]). In our animals, these changes occurred alongside elevated hepatic concentrations of IGFBP-2 mRNA and a reduction in both IGFBP-3 and the acid-labile subunit ([@bib16]).

One assumption is that, under these circumstances, IGFBP-2 forms a binary complex with IGF-II in order to facilitate circulatory transport to peripheral tissues and allow translocation of IGF-II through the capillary endothelium ([@bib3]). Within the oviduct, there was local expression of both IGF-I and IGF-II mRNAs, although in this tissue neither differed in relation to EB status. Oestradiol appears to be the major regulator of IGF-I within the reproductive tract ([@bib41]) and in oviduct IGF-I mRNA increases at oestrus ([@bib61]). In rats, GH can also increase uterine IGF-I expression ([@bib41]) although [@bib52] could detect no effect of bovine somatotrophin (bST) treatment on bovine endometrial IGF-I expression. However, in this latter experiment, bST did increase IGF-II mRNA in the oviduct on day 3 of the cycle. Our results across EB groups showed highly significant positive correlations between RT-PCR values for IGF-I, ERβ and GHR mRNAs, suggesting that both oestradiol and GH may be involved in the control of oviductal IGF-I production. The IGF-I mRNA concentration was also highly correlated with that of the glucocorticoid receptor. Follicular fluid contains high concentrations of cortisol, and it has been suggested that when this is released at ovulation it may influence the activity of the oviduct ([@bib76]). In late pregnant ewes, the surge release of cortisol induces a switch from IGF-II to IGF-I expression in foetal liver ([@bib18]), but this effect has not, to our knowledge, been investigated in the reproductive tract.

Previous evidence suggests that expression of IGF-I in the bovine oviduct is comparatively low, with greater production of IGF-II ([@bib72], [@bib52]). Isolated oviduct epithelial cells are capable of producing large amounts of IGF-II in culture ([@bib74], [@bib75], [@bib73]), and in the pig IGF-II levels in the oviductal fluid fluctuate in a cyclical manner and reach a peak just prior to oestrus ([@bib74]). Given the intrinsic ability of IGF-II to stimulate mitogenesis and prevent apoptosis, locally produced IGF-II may promote proliferation and metabolic activity of the oviduct itself ([@bib68]) and is also likely to be secreted into the lumen to influence development of the early embryo. The IGF-1R is detectable within bovine embryos from the two-cell stage onwards ([@bib35]).

The local expression of specific IGFBPs within individual tissues can provide information on IGF availability due to their intrinsic binding preferences. IGFBP-2 exhibits a relatively stronger affinity for IGF-II over IGF-I and likewise IGFBP-6 has an extreme (20- to 100-fold) preference for IGF-II ([@bib1]). Although the functional consequences of these relationships may vary, degradation of bound IGFBPs by proteolytic cleavage allows 'free IGF' to gain access to their receptors. IGFBP-6 is more resistant to proteolysis and studies have shown that the effects of IGF-II are generally inhibited by the presence of IGFBP-6 ([@bib23], [@bib2]). A relative reduction of oviductal IGFBP-6 and IGFBP-2 expression during SNEB may thus increase IGF-II signalling in the oviduct to counteract the low levels of circulating IGF-I during this time. This could act as a safety mechanism by allowing IGF-II to counteract the effects of NEB. Alternatively, as discussed below, this switch might have adverse consequences for fertility.

The concurrent reduction in IGFBP-2 and IGFBP-6 mRNA expression from opposing oviducts provides support for a systemic effect of NEB on the reproductive tract. Both IGFBP-2 and IGFBP-6 are sensitive to changes in reproductive hormones as shown by concurrent up-regulation during induced luteolysis in the bovine ovary ([@bib44]). A temporal effect on uterine IGFBP-6 expression levels during the oestrous cycle has also been demonstrated in the sheep, with maximal concentrations around ovulation and the early luteal phase ([@bib20]). In the rat, a putative oestrogen receptor-binding site has been characterised in the promoter region of the IGFBP-6 gene ([@bib78]). Furthermore, ovariectomy can attenuate IGFBP-6 expression in bone and uterus ([@bib25], [@bib20]), whereas administration of oestrogen increased IGF-II in embryonic cells ([@bib31]). In the study presented here, however, there were no differences in either plasma oestradiol or oviductal ERα or ERβ expression according to EB status. Across treatments, there was a significant positive relationship between IGFBP-6 and expression of GHR, however, neither GH concentrations nor GHR differed between the groups. Another potential regulatory agent is retinoic acid, which increases IGFBP-6 mRNA synthesis in a number of cell lines ([@bib1]). Major changes in retinol metabolism occur in the immediate postpartum period in dairy cows ([@bib26], [@bib39]), but were not assessed in the present study. In relation to IGFBP-2, there is considerable evidence that it is nutritionally responsive in certain tissues ([@bib69], [@bib11]). In support of this, we recently showed that IGFBP-2 mRNA was down-regulated in granulosa cells of SNEB cows, further implicating the regulation of this binding protein by energy balance in reproductive tissues ([@bib34]).

In general, there was excellent agreement between the PCR and *in situ* hybridisation data, even though the results for each technique were obtained from the opposing oviducts in each cow. For the PCR analysis, oviducts had been frozen whole, whereas the latter technique offered the additional benefit that it was possible to distinguish the different regions. When data from both treatments were pooled, overall analysis indicated that IGF-II expression was stronger in the isthmus when compared with the remainder of the oviduct, while IGFBP-6 showed the opposite with the weakest expression in the isthmus. Furthermore, the relative reduction of IGFBP-6 in SNEB oviducts was specifically attributable to a change in expression in the ampullary region. Based on the *in situ* hybridisation data, IGFBP-3 expression levels were significantly higher in the isthmus relative to the infundibulum. In the liver, IGFBP-3 expression is regulated concurrently with IGF-I (Woelfle & Rotwein 2004) and therefore elevated levels of IGFBP-3 suggest a relationship with relatively high levels of uterine IGF-I as previously reported ([@bib52]). These differences in expression patterns along the oviduct are likely to reflect the different structure and functions of these two regions. The ampulla has more secretory tissue and is functionally important for sperm capacitation and fertilisation, whereas the isthmus contains more smooth muscle and is important for sperm transport ([@bib13], [@bib27]).

Several studies have detected IGFBP-1 expression in human oviduct samples ([@bib53], [@bib55]), which was reduced in response to progesterone in culture ([@bib12]). The undetectable levels of IGFBP-1 transcript in the bovine in this study and others ([@bib73], [@bib54]) therefore appear to reflect species variation. The type-2 IGF receptor (IGF-2R) has not been studied in the oviduct previously and was only detected in 3 out of the 12 oviducts by quantitative RT-PCR. Transcript expression for other genes that can affect or mediate IGF transcription and signalling such as the receptors for insulin, IGF-I, GH, cortisol and oestrogen all remained unaltered by NEB.

In conclusion, the IGF system is relevant to many aspects of reproductive physiology and the involvement of these growth factors in the oviduct provides a potential link between nutritional status and fertility. We have shown that SNEB reduces both circulating IGF-I and the local expression of IGFBP-2 and IGFBP-6 (but not IGF-I or IGF-II) within the oviduct. This would predict enhanced IGF-II signalling, although conception rates are reduced in cows in NEB ([@bib71]). Many studies have investigated the effects of different culture systems for *in vitro* produced embryos. These have highlighted the fact that rates of embryo development and relative transcript abundance are both strongly influenced by the culture conditions (e.g. [@bib67]). Furthermore, a suboptimal environment for as little as 1 day can perturb subsequent long-term development potential ([@bib36]). IGF-II is an imprinted gene that mediates growth of early embryos and is known to have many profound effects on the formation of the foetus and placenta ([@bib17]). Foetal calf serum has been a common constituent of embryo culture medium. It contains active IGF-II ([@bib40]), causes faster development to the blastocyst stage ([@bib24]), but ultimately results in birth of fewer normal calves ([@bib14]). The fine control of energy metabolism by the embryo at this stage is also of crucial importance ([@bib67]). In the light of our results, we speculate that embryos from cows in SNEB experience altered IGF signalling within the oviduct, which likewise has adverse effects on their development, contributing to the high rates of embryo mortality seen in high-yielding dairy cows.

Materials and Methods
=====================

All chemicals and reagents were purchased from Sigma--Aldrich Company Ltd or VWR International Ltd (Poole, Dorset, UK) unless otherwise specified.

Animals and tissue collection
-----------------------------

All procedures were carried out under license in accordance with the European Community Directive, 86-609-EC. From an initial pool of 24 Holstein--Friesian cows with an average previous lactation yield of 6477±354 kg, 12 multiparous cows were randomly allocated 2 weeks prior to expected calving to either a MNEB or SNEB treatment, taking into account their parity, body condition score and previous lactation yield in a randomised block design. The mean parity numbers were 4.3 and 5.2 for the MNEB and SNEB groups respectively and the mean body condition scores (5-point scale with 0.25 increments) at calving were 3.5 and 4.0, with an overall ranges of 3.0--4.5. The treatments began on the morning after the second or third milking following parturition. MNEB cows were fed grass silage *ad libitum* with 8 kg/day of a 21% crude protein dairy concentrate and milked once daily; SNEB cows were fed 25 kg/day silage with 4 kg/day concentrate and milked thrice daily. Similar treatment groupings were shown in a previous study to produce differences in EB in early lactation ([@bib47]).

Energy balance was estimated as the difference between energy intake and the sum of energy for maintenance and milk production, based on measurements of milk yield, milk composition, liveweight and feed intake. The French NE system was used, where 1 unité fourragère lait (UFL) is the net energy for lactation equivalent of 1 kg standard air-dry barley (Jarrige 1989). The diameter of the first dominant follicle was determined for each cow from day 7 postpartum via daily transrectal ovarian ultrasonography (Aloka SSD-500 7.5 MHz transducer; Aloka Ltd, Tokyo, Japan). Cows were slaughtered on days 6--7 of the first follicular wave after calving. This design was chosen to collect tissue at a fixed time in relation to ovarian function to allow direct comparisons between tissues at the same stage of follicle development. Oviducts were collected at slaughter by manual separation from the ovary and cutting through the utero-tubal junction to separate from the uterus. Connective tissue was removed by dissection. The oviduct ipsilateral to the dominant follicle was frozen whole in liquid nitrogen for subsequent RNA extraction. For *in situ* hybridisation studies, the contralateral oviduct was coiled into a cardboard ring containing Cryo-M-Bed (Bright Instruments Co. Ltd, Huntingdon, UK) and placed on a sheet of metal cooled on dry ice. Once this had solidified, the rings were put into isopentane cooled in liquid N~2~ to freeze. Both sets of samples were then stored at −80 °C. The diameter of both uterine horns was measured ∼5 cm anterior to the bifurcation of the uterus, as an indicator of the process of uterine involution.

Blood samples were collected just prior to slaughter into lithium--heparin-primed vials and immediately placed on ice before centrifugation at 2000 ***g*** for 10 min. Plasma was decanted and stored at −20 °C for subsequent analysis. Samples of plasma were analysed for glucose, NEFA, BHB and urea using appropriate kits and an ABX Mira autoanalyser (ABX Mira, Montpellier, France). Concentrations of plasma IGF-I, insulin, GH and oestradiol were assayed as described previously ([@bib65], [@bib16], [@bib34]). Briefly, IGF-I concentrations were determined using the human OCTEIA IGF-I kit (IDS, Tyne and Wear, UK), the inter-assay coefficient of variation (CV) was 8.7% and the intra-assay CV values were 8.7 and 16.8% for samples with mean values of 81.5 and 4.7 ng/ml respectively. The sensitivity of the assay was 1.9 ng/ml. Insulin concentration in plasma was assayed using a solid-phase RIA (Coat-a-count; Diagnostics Products Corp., Los Angeles, CA, USA). The inter- and intra-assay CV values were 14.2 and 9.8% respectively. The minimum detectable limit of the assay was 1.6±0.03 μIU/ml. A double antibody RIA was used for GH determination where bovine GH (a gift from Dr J Gong, Roslin Institute, Edinburgh) was used for iodination and preparation of the standard curve ([@bib65]). The antiserum was raised in a guinea pig against bovine GH and was used at 1:10 000 dilution. The sensitivity of the assay was 1.6 ng/ml. The intra-assay coefficient of variation was 12.9%. Oestradiol concentrations were assayed using the Oestradiol MAIA assay kit (BioStat Diagnostic Systems, Stockport, UK). The intra-assay CV for samples with a mean of 1.1 and 4.6 oestradiol pg/ml of serum were 5.8 and 7.3% respectively and the sensitivity was 0.2 pg/ml. The intra-assay CV values for the same samples were 0.6 and 5.6% respectively. Cortisol concentrations were measured by RIA. Aliquots of 100 μl plasma were extracted with 3 ml diethyl ether in glass tubes, the organic phase was dried down and the sample was reconstituted in 300 μl assay buffer. Next, 100 μl aliquots of standard or extracted plasma were incubated with first antibody (100 μl sheep anti-bovine cortisol; Diagnostics Scotland; diluted 1:1000 in assay buffer) and \[1, 2, 6, 7-^3^H\]-cortisol (Amersham Biosciences UK Ltd; 100 μl, ∼10 000 c.p.m.) overnight at 4 °C. Separation was by dextran--charcoal. The intra-assay CV values for samples with means of 3.6 and 51.4 cortisol nmol/l of plasma were 5.6 and 6.1% respectively and the sensitivity of the assay was 0.7 nmol/l.

Real-time RT-PCR
----------------

Optimised PCR assays were used to detect transcripts for members of the IGF family including IGF-I/II, IGF receptors (IGF-1R/2R) and IGF-binding proteins (IGFBP-1/2/3/4/5/6), and also related factors including the receptors for IR-A/B, GHR, GRα and ERα/β. Primer sequence information is given in [Table 4](#tbl4){ref-type="table"}. A detailed description and applied conditions and protocols for these assays have been described and validated previously in bovine liver ([@bib16]). Briefly, total RNA was extracted from frozen whole oviduct tissue ipsilateral to the dominant ovarian follicle and homogenised in TRI reagent (Molecular Research Centre Inc., Cincinnati, OH, USA). Sample RNA concentration and purity was determined by spectrophotometry (NanoDrop Technologies Inc., Wilmington, DE, USA) where all samples had a 260/280 ratio of absorbance between 1.8 and 2.1. Any potential genomic DNA contamination was treated by incubating samples in the presence of DNase I in accordance with the manufacturer\'s instructions (Promega Corporation). Precisely, 1 μg DNase-treated RNA was converted to cDNA in a randomly primed RT reaction using reagents and instructions supplied by Promega. Standards for quantitative PCR were prepared from purified PCR products that were quantified by spectroscopy (NanoDrop) and diluted over at least eight orders of magnitude. Standards and samples were quantified by PCR in 20 μl reactions with SYBR green (Absolute QPCR SYBR green mix, ABgene, Surrey, UK) using the DNA Engine Opticon 2 (MJ Research Inc., Waltham, MA, USA). For all unknown oviduct samples, 50 ng reverse-transcribed RNA was added to each reaction in duplicate. To minimise variation, all samples included in each analysis were derived from the same RT batch, prepared under the same conditions throughout and were analysed on a single plate. A melting curve analysis was performed for each reaction to confirm specificity with previously sequenced amplification products. Data were recorded with the Opticon Monitor Analysis Software (V2.02; MJ Research, Inc.) and transcript expression levels were derived from standard curves of amplicons as described previously in bovine oviduct tissues ([@bib4]). Transcript levels for the ribosomal gene 18S were also analysed to account for sample variation through processing. Negative control samples were prepared as above minus the reverse transcriptase enzyme or cDNA to confirm the absence of genomic DNA and extraneous contamination respectively.

*In situ* hybridisation procedure
---------------------------------

Serial sections of 10 μm were thaw mounted onto SuperFrost Plus or POLYSINE microscope slides, fixed in 4% (w/v) paraformaldehyde in 0.01 M PBS (pH 7.0) for 5 min at room temperature, washed thrice with 0.01 M PBS (3 min each), dehydrated in 70% (5 min) and 95% (1 min) ethanol and stored at 4 °C in 95% ethanol prior to hybridisation. All probes used were single-stranded oligonucleotides of 45 bases in length previously validated in our laboratory on bovine ovary sections ([@bib34]; see [Table 5](#tbl5){ref-type="table"}). Briefly, the oligonucleotide probes (5 ng) were end labelled with \[^35^S\]dATP (Amersham Biosciences UK Ltd) using terminal deoxynucleotidyl transferase (Promega UK Ltd) at 34 °C for 1 h. Probe labelling efficiency averaged 38% (ranges 21--64%). The labelled probe was diluted to a final concentration of 100 000 c.p.m. 100/ μl in hybridisation buffer (50% (v/v) deionised formamide, 4× sodium saline citrate (SSC), 25 mM sodium phosphate, 1 mM sodium pyrophosphate, 5× Denhardt\'s solution, 0.2 mg/ml denatured salmon sperm DNA, 120 μg/ml sodium heparin, 100 μg/ml polyadenylic acid and 100 mg/ml dextran sulphate) and 100 μl was added to each slide. The slides were incubated in a humidified box overnight at 42, 45 or 52 °C ([Table 5](#tbl5){ref-type="table"}). Following incubation, the slides were washed in a solution of 1× SSC, 2 g/l sodium thiosulphate at room temperature for 30 min followed by fresh 1× SSC, 2 g/l sodium thiosulphate at 60 °C for 60 min. Slides were rinsed successively for 1 min in solutions of 1× SSC, 0.1× SSC, 75% ethanol and 95% ethanol and air-dried before exposure to β-max hyperfilm (Kodak BioMax MR Film) for either 4 or 5 days.

All oviduct sections treated with a particular probe were hybridised in the same batch. Sense probes, which were identical in sequence to the respective mRNA targets, were always included as negative controls and any signal from these was regarded as non-specific. Each batch also contained an appropriate positive control tissue, based on previous studies. These were cross sections of uterus from an oestrous ewe for IGF-I and the type 1 IGF receptor ([@bib62]), IGFBP-1 ([@bib45]) and IGFBP-6 ([@bib20]); ovine placentome for IGF-II and IGFBP-2, IGFBP-3 and IGFBP-4 ([@bib38]) and ovine intercotyledonary tissue for IGFBP-5 ([@bib46]).

To aid cellular localisation of hybridised probes, selected slides were subsequently coated with photographic emulsion LM1 (Amersham Biosciences UK Ltd) according to the manufacturer\'s instructions and stored for 28, 30 or 42 days at 4 °C in darkness ([Table 5](#tbl5){ref-type="table"}). The slides were developed in 20% phenisol (ILFORD Imaging UK Ltd, Cheshire, England), fixed in 1.9 M sodium thiosulphate and counterstained with haematoxylin and eosin. All other slides were also stained with haematoxylin and eosin to aid identification of tissue region. The oviducts were characterised by tubal region (isthmus, ampulla and infundibulum) according to [@bib27].

OD measurements
---------------

The relative expression of mRNA for components of the oviduct IGF system was quantified from the autoradiographs using the public domain NIH ImageJ program (available through the NIH website -- <http://www.nih.gov>), which calculated the average OD over the selected area of film based on a linear grey scale of 0.01--2.71. For each oviduct, the isthmus, ampulla and infundibulum regions were measured separately. Autoradiographs were scanned into a computer using a Hewlett--Packard Scanjet 5400c (Sheffield, UK) and OD measurements were recorded from digital images. Readings were obtained from at least two sections per tissue for each of the antisense (AS) and sense (S) probes. The background OD, from a blank area of film, was also measured and subtracted from both AS and S OD measurements. Finally, the S values were subtracted from AS values to give an average OD value for specific hybridisation ([@bib49]). The detection limit was taken as an OD value of 0.01.

Statistical analysis
--------------------

Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS for Windows, V13.0; SPSS Inc., Chicago, IL, USA). Data obtained by real-time PCR were expressed as fg/μg RT RNA and differences at the time of tissue collection between MNEB and SNEB groups were analysed using an independent samples *t*-test. Levene\'s test was used to account for variance and if homogeneity was not achieved an unequal variance *t*-test was used.

For OD measurements from the *in situ* hybridisation studies, the fixed effects of treatment and oviduct region on the level of mRNA expression for each probe were analysed by Linear Mixed Model analysis. Cow was entered as a random effect. For this purpose, data from oviducts in which a particular probe showed no detectable specific hybridisation (OD of \<0.01) were given an OD of 0.01, which equated to the lower limit of detection.

Relationships between absolute levels of expression for all genes measured by real-time PCR were determined from values pooled across treatment groups. The spread of data was tested for normality using the Shapiro--Wilk test and square root transformations were made (if appropriate) before deriving Pearson correlations. For the correlation data, only those relationships with *P*\<0.01 were considered. Results from all other analyses were considered statistically significant when *P*\<0.05.
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![Expression of IGF mRNA by *in situ* hybridisation in the oviduct of postpartum dairy cows in negative energy balance. Autoradiographic localisation of IGF-I (a and b), IGF-II (c and d) and IGF-1R (e and f). Examples of antisense (a, c and e) and sense (b, d and f) probes are illustrated. Amp, ampulla; Ist, isthmus; Ms, muscularis; Mc, mucosa. Scale bars=5 mm.](REP070243f01){#fig1}

![Expression of IGFBP mRNA by *in situ* hybridisation in the oviduct of postpartum dairy cows in negative energy balance. Autoradiographic localisation of IGFBP-2 (a and b), IGFBP-3 (c and d), IGFBP-4 (e and f), IGFBP-5 (g and h) and IGFBP-6 (i and j). Examples of antisense (a, c, e, g and i) and sense (b, d, f, h and j) probes are illustrated. Amp, ampulla; Ist, isthmus; Inf, infundibulum; Ms, muscularis; Mc, mucosa. Scale bars=5 mm.](REP070243f02){#fig2}

![Quantitative gene expression relationships in the postpartum bovine oviduct. Expression values obtained by real-time PCR for all cows regardless of NEB status (*n*=12). Significant associations (each *P*\<0.01) between genes are shown for IGF-I (*y*-axis; left) and GHR (*y*-axis; right).](REP070243f03){#fig3}

###### 

Concentrations of hormones and metabolic factors in serum of negative energy balance (NEB) cows at the time of tissue sampling.

  --------------------- ---------------------- ------------------------ -----------------------
                        **Mild NEB** (*n*=6)   **Severe NEB** (*n*=6)   **Difference** (*P* )
  *Endocrine*                                                           
   IGF-I (ng/ml)        51±8.4                 11±1.1                   0.001
   Insulin (μIU/ml)     0.22±0.058             0.13±0.019               0.178
   Oestradiol (pg/ml)   2.2±0.33               1.6±0.24                 0.137
   GH (ng/ml)           18±8.0                 9±0.7                    0.319
   Cortisol (nmol/l)    13±5.7                 5±1.6                    0.239
  *Metabolism*                                                          
   EB UFL per day       −2.7±1.41              −6.1±1.03                0.079
   NEFA (mM)            0.55±0.216             1.41±0.136               0.007
   BHB (mM)             0.59±0.097             3.71±0.201               \<0.001
   Glucose (mM)         4.1±0.13               2.7±0.15                 \<0.001
   Urea (mM)            4.0±0.46               5.1±0.31                 0.075
  --------------------- ---------------------- ------------------------ -----------------------

Values are mean±[s.e.m]{.smallcaps}. GH, growth hormone; EB, energy balance; NEFA, non-esterified fatty acid; BHB, β-hydroxybutyrate.

###### 

Expression levels of mRNA in oviduct of lactating cows maintained under mild or severe negative energy balance.

  ---------- -------------- ---------------- -----------------------
  **Gene**   **Mild NEB**   **Severe NEB**   **Difference** (*P* )
  IGF-I      4.4±1.01       3.3±1.71         0.415
  IGF-II     4.7±0.73       3.8±0.79         0.455
  IGF-1R     0.6±0.17       0.5±0.20         0.615
  IGF-2R     ND             ND               --
  IGFBP-1    ND             ND               --
  IGFBP-2    0.2±0.06       0.1±0.03         0.038
  IGFBP-3    3.9±0.48       2.4±0.51         0.051
  IGFBP-4    1.3±0.12       1.3±0.26         0.775
  IGFBP-5    3.7±0.35       5.5±1.16         0.170
  IGFBP-6    4.4±0.91       1.7±0.58         0.029
  IR-A       0.6±0.12       0.6±0.10         0.851
  IR-B       0.2±0.03       0.2±0.05         0.971
  GHR        0.5±0.15       0.3±0.19         0.398
  GRα        2.1±0.66       1.3±0.50         0.430
  ERα        21.9±2.48      23.6±3.75        0.756
  ERβ        8.0±2.97       6.0±2.67         0.625
  18SrRNA    64.5±11.36     69.2±10.94       0.865
  ---------- -------------- ---------------- -----------------------

Values are means±[s.e.m]{.smallcaps}. Values are expressed in fg/μg RT RNA, except 18SrRNA, which is in pg/μg RT RNA. ND, not detectable in all samples.

###### 

Expression of the insulin-like growth factor (IGF) system by *in situ* hybridisation in oviduct tissue of the dairy cow during negative energy balance (NEB).

  ----------- ---------------- ----------------- ----------------------- -------- -------- ---------------- ---------------- -------- -----------
              **Region**       **Treatment**     **Difference** (*P* )                                                                
                                                                                                                                      
  **Probe**   Isthmus          Ampulla           Infundibulum            Muscle   Mucosa   mNEB             sNEB             Region   Treatment
  IGF-I       0.047±0.015      0.057±0.013       0.046±0.016             −        \+       0.058±0.020      0.042±0.018      0.298    0.566
  IGF-II      0.104±0.008^a^   0.077±0.006^b^    0.078±0.009^b^          \+       \+       0.089±0.009      0.084±0.009      ≤0.001   0.669
  IGF-1R      0.042±0.007      0.052±0.004       0.050±0.007             −        \+       0.047±0.005      0.049±0.006      0.320    0.854
  IGFBP-2     0.043±0.008      0.052±0.005       0.054±0.008             \+       \+       0.061±0.008      0.039±0.008      0.365    0.068
  IGFBP-3     0.125±0.013^a^   0.103±0.011^ab^   0.096±0.014^b^          \+       \+       0.103±0.016      0.114±0.016      0.035    0.645
  IGFBP-4     0.064±0.009      0.046±0.007       0.042±0.011             \+       \+       0.061±0.009      0.040±0.010      0.056    0.125
  IGFBP-5     0.119±0.013^a^   0.085±0.010^b^    0.086±0.014^b^          ++       −        0.089±0.015      0.105±0.015      0.004    0.447
  IGFBP-6     0.078±0.030^b^   0.216±0.024^a^    0.212±0.034^a^          \+       ++       0.245±0.034^x^   0.092±0.035^y^   ≤0.001   0.009
  ----------- ---------------- ----------------- ----------------------- -------- -------- ---------------- ---------------- -------- -----------

Values are mean±[s.e.m]{.smallcaps}. optical density units analysed by linear mixed model. *n*=6 cows per treatment group; isthmus was not present in oviduct sections from three MNEB and three SNEB cows. +/− symbols indicate relative intensity of hybridisation where ++ is strong, + is weak, and − is no specific hybridisation. ^ab^Within rows, values with different superscripts are significantly different between oviduct regions. ^xy^Within rows, values with different superscripts are significantly different between energy balance treatment groups.

###### 

Oligonucleotide primer sequence information used for real-time PCR assays.

  ---------- ----------------------------------- ----------------------- --------------------------------------
  **Gene**   **Primer sequence** (5′→3′)         **GenBank accession**   **Product length** (bp)
  IGF-I      Forward: AGTTGGTGGATGCTCTCCAGT      X15726                  115[a](#tblfn2){ref-type="table-fn"}
             Reverse: CACTCATCCACGATTCCTGTC                              
  IGF-1R     Forward: GATCCCGTGTTCTTCTACGTTC     X54980                  101[a](#tblfn2){ref-type="table-fn"}
             Reverse: AAGCCTCCCACTATCAACAGAA                             
  IGF-II     Forward: GCTTCTACTTCAGCCGACCAT      X53553                  110[a](#tblfn2){ref-type="table-fn"}
             Reverse: GGCACAGTAAGTCTCCAGCAG                              
  IGF-2R     Forward: TACAACTTCCGGTGGTACACCA     AJ320234                111[a](#tblfn2){ref-type="table-fn"}
             Reverse: GGATTTCGCTAGCCTGGAGAG                              
  IGFBP-1    Forward: TCAAGAAGTGGAAGGAGCCCT      NM_174554               127[a](#tblfn2){ref-type="table-fn"}
             Reverse: AATCCATTCTTGTTGCAGTTT                              
  IGFBP-2    Forward: AGGGTGGCAAACATCACCT        NM_174555               120[a](#tblfn2){ref-type="table-fn"}
             Reverse: GAAGGCGCATGGTGGAGAT                                
  IGFBP-3    Forward: ACAGACACCCAGAACTTCTCCTC    NM_174556               102[a](#tblfn2){ref-type="table-fn"}
             Reverse: GTTCAGGAACTTGAGGTGGTTC                             
  IGFBP-4    Forward: GACCTTTACATCATTCCCATCC     NM_174557               129[a](#tblfn2){ref-type="table-fn"}
             Reverse: AAGCTTCACTCCCGTCTTCC                               
  IGFBP-5    Forward: CAAGCCAAGATCGAAAGAGACT     S52657                  86[a](#tblfn2){ref-type="table-fn"}
             Reverse: AAGATCTTGGGCGAGTAGGTCT                             
  IGFBP-6    Forward: GGAGAGAATCCCAAGGAGAGTAA    AY197339                100
             Reverse: GAGTGGTAGAGGTCCCCGAGT                              
  IR-A       Forward: TCCTCAAGGAGCTGGAGGAGT      AJ488553                89
             Reverse: TTTCCTCGAAGGCCTGGGGAT                              
  IR-B       Forward: TCCTCAAGGAGCTGGAGGAGT      AJ320235                111
             Reverse: TAGCGTCCTCGGCAACAGG                                
  GHR        Forward: ACTTGGGCTAGCAGTGACATTA     NM_176608               101[a](#tblfn2){ref-type="table-fn"}
             Reverse: TTCCTTTAATCTTTGGAACTGG                             
  GRα        Forward: CTGGGGCCAATATAATTGGTAA     DQ192585                124
             Reverse: TTCTGATCCTGCTGTTGAGAAA                             
  ERα        Forward: TCAGGCTACCATTACGGAGTTT     NM_001001443            120[a](#tblfn2){ref-type="table-fn"}
             Reverse: GTTTTTATCAATCGTGCACTGG                             
  ERβ        Forward: CTTCGTGGAGCTCAGCCTGT       NM_174051               262[a](#tblfn2){ref-type="table-fn"}
             Reverse: GAGATATTCTTTGTGTTGGAGTTT                           
  18SrRNA    Forward: CGGCGACGACCCATTCGAAC       AY779625                99
             Reverse: GAATCGAACCCTGATTCCCCGTC                            
  ---------- ----------------------------------- ----------------------- --------------------------------------

Gene products analysed are IGF type I/II (IGF-I/II) and receptors (IGF-1R/2R), IGF-binding proteins 1--6 (IGFBP-1/2/3/4/5/6), insulin receptor type A/B (IR-A/B), growth hormone receptor (GHR), glucocorticoid receptor α (GRα) and oestrogen receptor αβ (ERαβ).

Amplified product spans at least one boundary between adjacent exons.

###### 

Sense oligonucleotide probe sequences used for *in situ* hybridisation analysis and the exposure times for X-ray films and photographic emulsions.

  ------------------------------------------ ----------------------------------------------------------------- ---------------------------- ------------------------------------ -------------------------- -------------------------------------
                                                                                                                                                                                 **Exposure time** (days)   
                                                                                                                                                                                                            
  **Probe**                                  **Sequences**                                                     **Accession ID alignment**   **Hybridisation temperature** (°C)   X-ray film                 Emulsions
  IGF-I                                      Sense: 5′-TCACATCCTCCTCGCATCTCTTC TATCTGGCCCTGTGCTTGCTCG-3′       NM_001077828                 45                                   7                          42
                                             Antisense: 5′-CGAGCAAGCACAGGGCCAGATAGAAGA GATGCGAGGAGGATGTGA-3′                                                                                                
  IGF-II                                     Sense: 5′-CCAGCGAGACTCTGTGCGGCGGG GAGCTGGTGGACACCCTCCAGT-3′       NM_174087                    52                                   4                          30
                                             Antisense: 5′-AACTGGAGGGTGTCACCAGCTCCCCGCCG CACAGAGTCTCGCTGG-3′                                                                                                
  IGF-1R[a](#tblfn3){ref-type="table-fn"}    Sense: 5′-CTCACGGTCATCCGCGGCTGGAAACTCTTCTA CAACTACGCCCTG-3′       XM_871496                    42                                   4                          42
                                             Antisense: 5′-CAGGGCGTAGTTGTAGAAGAGTTTC CAGCCGCGGATGACCGTGAG-3′                                                                                                
  IGFBP-1                                    Sense: 5′-GGAGAGCCTGGGCTCTGTTGGTGTGTC TACCCTTGGAGTGGGAAG-3′       NM_174554                    45                                   5                          --[b](#tblfn4){ref-type="table-fn"}
                                             Antisense: 5′-CTTCCCACTCCAAGGGTAGACACACCAACA GAGCCCAGGCTCTCC-3′                                                                                                
  IGFBP-2[c](#tblfn5){ref-type="table-fn"}   Sense: 5′-GCGCCAGCCCCGAGCAGGTTGCAGACAATGGC GAGGAGCACTCTG-3′       NM_174555                    45                                   4                          42
                                             Antisense: 5′-CAGAGTGCTCCTCGCCATTGTCTG CAACCTGCTCGGGGCTGGCGC-3′                                                                                                
  IGFBP-3                                    Sense: 5′-GAGTCGGAAGAAGACCACAGCATGGGGAGCA CAGAGAACCAGGCT-3′       NM_174556                    45                                   4                          28
                                             Antisense: 5′-AGCCTGGTTCTCTGTGCTCCC CATGCTGTGGTCTTCTTCCGACTC-3′                                                                                                
  IGFBP-4                                    Sense: 5′-AAGACGGGAGTGAAGCTTCCGGGGGGCCTG GAGCCGAAGGGGGAG-3′       NM_174557                    45                                   5                          42
                                             Antisense: 5′-CTCCCCCTTCGGCTCCAGGCCCCCCG GAAGCTTCACTCCCGTCTT-3′                                                                                                
  IGFBP-5                                    Sense: 5′-CTACTCGCCCAAGATCTTCCGGCCCAAGCA CACCCGCATCTCCGA-3′       S52657                       42                                   4                          28
                                             Antisense: 5′-TCGGAGATGCGGGTGTGCTTGGGCCGGAA GATCTTGGGCGAGTAG-3′                                                                                                
  IGFBP-6                                    Sense: 5′-CTCTACGTGCCTAATTGTGACCATAGGGGCTTC TACCGGAAGCGG-3′       NM_001040495                 42                                   5                          42
                                             Antisense: 5′-CCGCTTCCGGTAGAAGCCCCTATGGTCA CAATTAGGCACGTAGAG-3′                                                                                                
  ------------------------------------------ ----------------------------------------------------------------- ---------------------------- ------------------------------------ -------------------------- -------------------------------------

The bovine IGF-1R gene sequence is predicted, but the oligonucleotide probe shares 100% homology with the human IGF-IR gene (NM_000875.3).

Autoradiography revealed no hybridisation, so emulsions were not prepared.

Sequence is 97% homologous with the predicted bovine IGFBP-2 transcript.
